Standard Chartered Beats Profit Forecasts as First-Half Earnings Rise 9% 
Colgate-Palmolive Reaffirms 2026 Sales Outlook Despite Weak North America Demand 
Russia Charges Telegram Founder Pavel Durov With Facilitating Terrorism, Seeks International Arrest 
Sony Raises Full-Year Outlook After Q1 Profit Jumps 40% on Gaming and Chip Growth 
Roblox Stock Drops 16% as Q3 Bookings Forecast Misses Expectations 
Japan Earthquake Disrupts Auto and Chip Supply Chains 
Meta-backed research finds exposure to ‘untrustworthy’ social media is rare. The fine print is less reassuring 
Holcim Raises 2026 Outlook After Strong Q2 Earnings Beat 
Anthropic Reveals Claude AI Accessed Real Production Systems During Cybersecurity Tests 
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline 
Meta Stock Drops After Earnings Miss as AI Spending and Legal Costs Weigh on Profit 
Rio Tinto Stock Jumps as Strong Earnings, Higher Dividend and AI Metal Demand Boost Outlook 
Sony Eyes $1.3 Billion Tamron Acquisition as Lens Maker Reviews Offer 
X Challenges Australia’s Expanded Social Media Ban Enforcement Powers 
SpaceX Wins $1.6 Billion U.S. Space Force Launch Contracts for Falcon 9 Missions Through 2027 
Same sparkle, different story: how lab-grown diamonds are transforming the market 
Apple Q3 Earnings Beat as Record iPhone Sales Offset Services, China Weakness 
EMERYVILLE, Calif., May 03, 2018 -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that it successfully collaborated with its fragrance partner, Firmenich, to support the development and commercialization of Z11. This sustainable and cost-effective version of Firmenich’s iconic Z11 molecule was developed using Amyris’s disruptive proprietary technology to develop a reliable and sustainable supply of an intermediate, using a fermentation-based production process, for which Firmenich has then applied its state of the art, proprietary green chemistry.
“We are pleased with our ability to support Firmenich’s product innovation as they continue to be a leader in developing game-changing ingredients for their customers,” said John Melo, President & CEO of Amyris. “Amyris has collaborated with Firmenich since 2010, successfully growing a palette of bio-based fragrance ingredients and intermediates as Firmenich continues their legacy of providing the finest ingredients well into the future, with the added benefit of being derived from a sustainable resource.”
About Amyris
Amyris is the integrated renewable products company that is enabling the world’s leading brands to achieve sustainable growth. Amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products. The company is delivering its No Compromise® products across a number of markets, including specialty and performance chemicals, flavors and fragrances, cosmetics ingredients, pharmaceuticals, and nutraceuticals. More information about the company is available at www.amyris.com.
Amyris and the Amyris logo are trademarks or registered trademarks of Amyris, Inc. in the U.S. and/or other countries. All other trademarks are the property of their respective owners.
Contact:
Peter DeNardo
Director, Investor Relations and Corporate Communications
Amyris, Inc.
+1 (510) 740-7481
[email protected]
[email protected]
